Popular Healthcare Stocks in India
- Share.Market
- 4 min read
- 04 Mar 2024
India’s healthcare sector throbs with a vibrant pulse! Imagine a billion-strong population driving demand for medical marvels, from budget-friendly breakthroughs to cutting-edge technology. This confluence of necessity and innovation creates a medical landscape with investment possibilities.
Union Budget 2023-24 allocates over ₹89,000 crore to healthcare, with key allocations to PMSSY, medical education, National Health Mission, and AB-PMJAY.
Scheme | Union Budget Allocation(in Crore) |
Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) | ₹ 3,365 |
Human Resources for Health and Medical Education | ₹ 6,500 |
National Health Mission | ₹ 29,085 |
Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) | ₹ 7,200 |
In this blog, let’s learn about popular Nifty Healthcare stocks.
List of Popular Healthcare Stocks
Here is a rundown of Nifty Healthcare stocks, with details on their market capitalisation and stock prices.
Nifty Healthcare Stocks | Sub-Segments | Market Capitalisation (in Cr) | Stock Price (closing of 4th March 2024) |
Abbott India Ltd. | Pharmaceuticals | ₹59,885 | ₹27,540 |
Alkem Laboratories Ltd. | Pharmaceuticals | ₹61,057 | ₹5,124.90 |
Apollo Hospitals Enterprise Ltd. | Healthcare Providers & Services | ₹88,188 | ₹6,033.30 |
Aurobindo Pharma Ltd. | Pharmaceuticals | ₹61,348 | ₹1,090.90 |
Biocon Ltd. | Biotechnology & Medical Research | ₹33,251 | ₹278.90 |
Cipla Ltd. | Pharmaceuticals | ₹1,18,671 | ₹1,471.50 |
Divi’s Laboratories Ltd. | Pharmaceuticals | ₹93,140 | ₹3,482.30 |
Dr. Lal Path Labs Ltd. | Healthcare Providers & Services | ₹19,435 | ₹2,275.25 |
Dr. Reddy’s Laboratories Ltd. | Pharmaceuticals | ₹1,07,228 | ₹6,335.10 |
Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | ₹26,194 | ₹921.70 |
Granules India Ltd. | Pharmaceuticals | ₹11,273 | ₹467 |
Ipca Laboratories Ltd. | Pharmaceuticals | ₹30,418 | ₹1,201.80 |
Laurus Labs Ltd. | Pharmaceuticals | ₹22,038 | ₹417.55 |
Lupin Ltd. | Pharmaceuticals | ₹74,019 | ₹1,669.85 |
Max Healthcare Institute Ltd. | Healthcare Providers & Services | ₹77,102 | ₹747.40 |
Metropolis Healthcare Ltd. | Healthcare Providers & Services | ₹8,775 | ₹1,674.00 |
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | ₹3,72,029 | ₹1,552.10 |
Syngene International Ltd. | Biotechnology & Medical Research | ₹29,377 | ₹697.10 |
Torrent Pharmaceuticals Ltd. | Pharmaceuticals | ₹91,093 | ₹2,690.85 |
Zydus Lifesciences Ltd. | Pharmaceuticals | ₹90,471 | ₹946.25 |
Note: The above healthcare data is from 4th March 2024. For the latest updates on stock prices and market trends, check out the share.market stocks page today!
Key Considerations Before Investing in Healthcare Stocks in India
Investors looking to invest in healthcare sector stocks should be aware of the various factors that can affect prices. By taking into account these factors, investors can better understand how their investments may be impacted and make more informed decisions.
Regulatory Impact
Changes in healthcare regulations significantly influence stock prices. New policies, like drug pricing or insurance coverage rules, may increase industry costs, leading to lower stock valuations. Tax law adjustments, such as deductions for medical research, also sway stock prices.
Industry Dynamics
Healthcare stocks are affected by industry trends, including technological advancements, shifting consumer preferences, and evolving treatments. Staying updated on sector news helps investors track market shifts for informed investment choices.
Competition from New Entrants
The potential disruption from new players entering the healthcare market can impact existing companies. Increased competition may reduce earnings, lowering stock prices and creating a more competitive landscape.
Geopolitical Influence
Geopolitical events, such as trade wars or economic sanctions, disrupt healthcare sectors. Supply chain disturbances may affect companies’ ability to meet consumer demand, resulting in decreased stock prices.
Conclusion
India’s healthcare sector buzzes with vitality! A billion-strong populace drives demand for medical breakthroughs, from medical innovations to cutting-edge technology. The Union Budget 2023-24 allocates over ₹89,000 crore to healthcare, marking it as a priority.
Recognising factors like regulatory impacts, industry dynamics, competition, and geopolitical influences becomes pivotal for astute investment decisions as we navigate through popular Nifty Healthcare stocks.
Stay disciplined, avoid hasty tips, and adjust your portfolio sensibly. In the ever-changing auto sector, strategic and well-researched investments are crucial to building a portfolio that best fits your financial goals.
FAQs
Healthcare stocks represent shares in companies related to medical services, pharmaceuticals, and health products. Investors buy these stocks to own a part of businesses contributing to healthcare, aiming for potential profit as the companies grow and succeed in the medical industry.
There are risks in investing in healthcare stocks. Factors like changes in regulations, drug trial outcomes, and competition can affect stock prices. Researching thoroughly and staying updated on industry developments is essential to make informed investment decisions.